Lesson plan
MIPT
Methylisopropyltryptamine (MiPT), also known as N-methyl-N-isopropyltryptamine, is a psychedelic drug of the tryptamine family related to other psychedelics like dimethyltryptamine (DMT) and diisopropyltryptamine (DiPT). It is taken orally. The drug acts as a serotonin receptor modulator, including as an agonist of the serotonin 5-HT 2A receptor. Derivatives of MiPT include 4-HO-MiPT (miprocin) and 5-MeO-MiPT (moxy). MiPT was first described by David Repke and colleagues in 1981. It was subsequently evaluated and described in Alexander Shulgin's 1997 book TiHKAL (Tryptamines I Have Known and Loved). MiPT was encountered as a novel designer drug by 2005.
Article summary
Methylisopropyltryptamine (MiPT), also known as N-methyl-N-isopropyltryptamine, is a psychedelic drug of the tryptamine family related to other psychedelics like dimethyltryptamine (DMT) and diisopropyltryptamine (DiPT). It is taken orally. The drug acts as a serotonin receptor modulator, including as an agonist of the serotonin 5-HT 2A receptor. Derivatives of MiPT include 4-HO-MiPT (miprocin) and 5-MeO-MiPT (moxy). MiPT was first described by David Repke and colleagues in 1981. It was subsequently evaluated and described in Alexander Shulgin's 1997 book TiHKAL (Tryptamines I Have Known and Loved). MiPT was encountered as a novel designer drug by 2005.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.